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Introduction
The incidence of  metastasis to the thyroid gland in autopsy series has been reported to range between 
1.25-24%1. The most common sources of  metastases are renal cell carcinoma, breast carcinoma, and lung 
carcinoma1,2. Clinically apparent spread of  malignant melanoma to the thyroid gland is rare, accounting for 
less than 5% of  metastatic tumors to the thyroid1.   
We present a case of  a patient with malignant melanoma metastatic to the thyroid gland as an early 
manifestation of  distant metastatic disease, as well as a review of  the literature. 
Case Report
A 68-year-old male with a 30 pack year tobacco history presented with a 1.5cm left posterior triangle 
neck mass. Physical exam and radiographs performed at the time failed to reveal a primary tumor.  An 
FNA of  the mass at the time revealed a poorly differentiated squamous cell carcinoma.  The patient was 
taken to the operating room for staging endoscopy and a repeat FNA.  Again, there was no evidence of  
a primary lesion, but FNA at this time was suggestive of  melanoma, and this diagnosis was confirmed via 
immunophenotyping, which showed the cells staining positive for Melan A and S-100 (Figure 1).  Biopsies 
of  the tonsil, nasopharynx and tongue base were negative.  The patient then underwent a left modified 
radical neck dissection.  The posterior triangle mass was discovered to be a lymph node which tested 
positive for malignant melanoma. All other nodes were negative. No primary site for the melanoma was 
found, and the patient was scheduled for radiation therapy and chemotherapy. However, the patient was 
reluctant to receive these treatments during follow-up.
Eighteen months later, the patient presented with a 10cm midline neck mass representing a diffusely 
enlarged thyroid gland. An FNA was performed which revealed melanoma. The patient underwent an MRI 
of  the neck, revealing a diffusely enlarged cystic thyroid gland with no cervical adenopathy (Figure 2). 
Two weeks later, the patient began having seizures, and an MRI of  the brain revealed a 1.7cm mass in 
the region of  the anterior superior vermis, with associated mass effect and mild hydrocephalus. This was 
suspicious for metastasis. A CT scan of  the chest, abdomen, and pelvis was obtained, showing a soft tissue 
lesion in the suprapubic region consistent with metastasis. The patient soon developed ventilator dependent 
respiratory failure, and was taken for a subtotal thyroidectomy for establishment of  a tracheostomy (Figure 3). 
Histology showed the thyroid largely being replaced by metastatic melanoma with extensive necrosis 
(Figure 4). The patient subsequently required placement of  a ventriculoperitoneal shunt to treat the 
hydrocephalus secondary to the metastatic brain lesion.   
Discussion
The case presented above is similar to the few other case reports detailing metastatic melanoma to the 
thyroid gland.  As with our patient, the most common complaint among patients with metastatic disease 
to the thyroid gland is a neck mass3,4. Some authors have found that the pathology shows replacement 
of  the thyroid by melanoma, but thyroid function remains preserved5-7. Our patient had no evidence of  
hypothyroidism—his laboratory abnormalities (slightly decreased TSH, normal free T4) likely represent the 
slight variation in thyroid function tests seen in euthyroid sick syndrome.  Shimaoka et al describes a likely 
explanation for this phenomenon—it takes weeks to months for total ablation of  thyroid function to 
manifest as hypothyroidism, and most patients do not survive long enough with metastatic tumor for 
hypothyroidism to become apparent8.   It has been suggested that pre-existing abnormalities of  the 
thyroid, such as nodules or adenomas, predisposes it to metastatic lesions9,10. Our patient did not have such 
abnormalities. 
Various autopsy studies have revealed the incidence of  malignant melanoma metastasizing to the thyroid 
gland to be high.  Although Nakhjavani et al1 found melanoma to account for less than 5% of  clinically 
apparent metastatic thyroid tumors, autopsy studies have shown the number to be as high as 35% of  
all metastatic lesions to the thyroid9. The disparity can be explained by the fact that in autopsy studies, 
metastatic lesions are discovered only upon microscopic examination of  small, careful cuts of  the gland. In 
autopsy studies focused only on patients with melanoma, Patel et al found the incidence of  thyroid 
metastases to be 26% in the 261 autopsies performed11. Shimaoka et al found thyroid metastases in 39%8.    It is 
not surprising that melanoma has such a high propensity for the thyroid given its vascularity and the 
hematogenous route of  spread.  Melanoma has the ability to metastasize to almost every organ, with the 
most common sites being lungs, liver and brain11. Although patients with melanoma may have thyroid 
metastases without consequence, it is rare that a mass in the thyroid would be their only clinically apparent 
sign of  metastatic melanoma.  Although our patient was discovered to have additional inguinal lymph node 
and brain metastases during his hospital course, it was his enlarged thyroid gland that was the early indication 
of  distant metastases. 
 Metastases of  any malignancies to the thyroid are much more common than one would expect. The 
incidence of  metastases in the thyroid gland is fairly high in patients with known metastatic tumors.  One 
autopsy study of  7332 patients with known malignancy showed 2.8% with thyroid metastases14. Others have 
reported incidences as high as 9.5%8.  Combining studies, a representative figure is 5-6%. These surprising 
numbers have prompted some to state that metastatic thyroid neoplasms may be 10 times as numerous as 
primary thyroid cancers8. Watts reports that of  six patients presenting with a thyroid nodule who had a past 
history of  malignancy, four had cytologic evidence of  metastasis12.  This led him to conclude, along with 
Shimaoka et al, that in a patient with a history of  cancer, a metastatic thyroid nodule is more likely than a 
primary8,12. 
Our case allows for discussion of  the diagnosis and management of  thyroid metastases.  FNA has 
been reported to be the initial procedure of  choice in diagnosis of  metastatic lesions to the thyroid12,13. 
Once discovered, metastases to the thyroid must be managed very differently than lymphomas or 
primary thyroid tumors. A secondary neoplasm to the thyroid indicates a poor prognosis.  Metastases to the 
thyroid predominates in the 6th-8th decades of  life, and these patients additionally have a worse prognosis 
secondary to advanced age2,4. More importantly, thyroid metastases are usually part of  a widely disseminated 
malignancy.  In most reports of  metastases to the thyroid gland, other metastatic deposits are identified at or 
soon after the discovery of  the lesion.   With the exception of  metastases from renal cell carcinoma, Rosen 
et al showed patient survival less than 2 years after discovery of  thyroid metastases13. McCabe et al reported 
an average survival of  12 months4. In discussing melanoma specifically, patients with metastatic melanoma 
have a median survival of  24 months, irrespective of  site of  metastasis11. Less than 1% of  melanoma 
patients have single organ metastasis, and when combined with other poor prognostic indicators, surgical 
management of  metastatic melanoma is most often limited to palliative measures11. Thyroidectomy is an 
accepted procedure for relief  from dyspnea or dysphagia, or as in our patient, performing a tracheostomy.  In 
the rare case that the thyroid is the only site of  metastatic deposits, thyroidectomy can be curative3. 
Any patient with a history of  malignancy and a thyroid nodule presents a diagnostic dilemma.  Is it a benign 
nodule, a new primary, or a metastasis?  The FNA can be very helpful in distinguishing these entities. If  it 
represents metastatic disease, is it a “new” metastasis suggesting a neoplastic recurrence, or is it merely the 
growth of  microscopic deposits from a much earlier neoplasm?  Others have authored similar dilemmas 
- Ivy describes melanoma in the thyroid gland years before and years after the primary lesion is discovered2. 
Nakhjavani et al report months between detection of  primary malignancy and metastases to the thyroid1. 
Our case is especially difficult as no primary lesion was ever found.  However, given the high incidence of  
thyroid metastases in malignancy, and given the long time period between initial neoplasm and discovery 
of  thyroid metastases, we must agree with Nakhjavani et al that any patient with a previous history of  
malignancy with a thyroid mass should be considered as having metastases until proven otherwise1.  
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Abstract
Objectives: The thyroid gland is a relatively uncommon site for secondary malignancy. Even less 
common is metastasis of  malignant melanoma to the thyroid gland. We present a case of  malignant 
melanoma metastatic to the thyroid gland presenting as thyroid enlargement.
Study Design: This is a case report which utilizes chart review, intraoperative photographs, 
radiographic images, and pathology slides.
Methods: A 68 year old patient with no prior evidence of  primary skin melanoma presented with 
a neck mass which tested positive for melanoma. A year and a half  following modified radical neck 
dissection, the patient presented with a diffusely enlarged thyroid gland from which fine needle 
aspiration revealed metastatic malignant melanoma. 
Results: A few months following this, the patient began having seizures and was found on MRI 
to have metastatic disease to the brain. He developed ventilator dependent respiratory failure and 
required a subtotal thyroidectomy for the placement of  a tracheostomy tube.
Conclusions: Patients with a history of  malignancy and a thyroid nodule present a diagnostic 
dilemma—is it benign, a new primary, or distant metastasis? Review of  this case and the literature 
strengthens the argument that any patient with a history of  malignancy and a thyroid mass should 
be considered as having metastasis until proven otherwise.
Figure 2: a) Axial T1W MRI showing enlarged thyroid gland, b) Coronal T2W MRI showing similar findings.
Figure 3: a) Intraoperative view of enlarged 
thyroid gland; b) division of thyroid gland to facilitate 
removal prior to tracheostomy; c) gross subtotal 
thyroid specimen removed. Note the extensively 
pigmented thyroid parenchyma.
Figure 4: a) H&E stain, 2x view showing extensive replacement of thyroid parenchyma by nests of melanoma and 
considerable necrosis; b) 40x view showing melanoma on the left and thyroid on the right—two thyroid follicles 
are seen.
Figure 1: a) S-100 stain of melanoma cells from FNA specimen, b) Melan-A stain from FNA specimen
